Related Experiment Video
Updated: Feb 4, 2026

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016
Lamprini Veneti1,2, Katrine Borgen1, Kaja Sverdrup Borge1
1Division for Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Abstract:
From 6 September 2015-May 2016, a large mumps outbreak occurred among vaccinated students in Norway. A case was defined as a person presenting with a clinical mumps infection, notified between 1 September 2015 and 30 June 2016. Confirmed cases had positive laboratory confirmation and probable cases had an epidemiological link; PCR-positive specimens were genotyped. A total of 232 cases were notified (230 confirmed) with median age of 23 years (range 4-81) and 61% were male. Of 68 (30%) confirmed cases that were genotyped, 66 were genotype G and associated with the outbreak. Cases that had received two doses of the measles-mumps-rubella (MMR) vaccine had reduced risk of hospitalisation (adjusted relative risk (aRR): 0.14; 95%CI: 0.03-0.57), mumps-related orchitis (aRR: 0.21; 95% CI: 0.08-0.55) and severe outcome (aRR: 0.25; 95% CI: 0.10-0.62) compared with those unvaccinated. A third dose of the vaccine was offered to approximately 1,300 fully vaccinated close contacts and subsequently reported cases decreased. This large outbreak, occurring among predominately vaccinated students, suggests the current genotype A vaccine offers suboptimal protection against mumps genotype G. We recommend maintaining high vaccination coverage and offering the vaccine to all unvaccinated individuals.
Insights
A 2015-2016 Norway mumps outbreak in vaccinated students revealed genotype G strains. Two measles-mumps-rubella (MMR) vaccine doses reduced hospitalization and severe outcomes, but protection against genotype G was suboptimal.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- Mumps outbreaks can occur in highly vaccinated populations.
- The measles-mumps-rubella (MMR) vaccine, typically genotype A, is used globally.
- Understanding vaccine effectiveness against circulating mumps genotypes is crucial.
Purpose of the Study:
- To investigate a large mumps outbreak in Norway among vaccinated students.
- To determine the genotype of the mumps virus involved in the outbreak.
- To assess the effectiveness of the measles-mumps-rubella (MMR) vaccine during the outbreak.
Main Methods:
- Case definition: clinical mumps infection notified between September 2015 and June 2016.
- Laboratory confirmation and PCR-based genotyping of suspected cases.
- Statistical analysis to compare outcomes between vaccinated and unvaccinated individuals.
Main Results:
- 232 cases notified, predominantly in individuals aged 23 years; 61% were male.
- 66 of 68 genotyped cases were identified as mumps genotype G.
- Two MMR vaccine doses significantly reduced the risk of hospitalization (aRR: 0.14), orchitis (aRR: 0.21), and severe outcomes (aRR: 0.25).
Conclusions:
- The mumps genotype G outbreak in vaccinated students suggests suboptimal protection from the current genotype A vaccine.
- Maintaining high vaccination coverage and vaccinating unvaccinated individuals are recommended.
- Further research into vaccine efficacy against diverse mumps genotypes is warranted.
Related Concept Videos
Vaccinations
Student t Distribution
The Student t distribution was developed by William S. Goset (1876–1937) of the...
Microsoft Excel: Student's t-Test
To conduct a t-test in Excel, use the T.TEST function or the "Data...
Steps in Outbreak Investigation
What are Viruses?
Comparing Experimental Results: Student's t-Test

